However, along with its potent anti-hyperglycemia effects, insulin also carries a high risk of hypoglycemia, often leads to weight gain, and some types of insulin have been linked to increased rates of several cancers (Karlstad 2013
Care Med ., 2006 , 174 , 530
Most patients lose 15 pounds in 8 to 16 weeks on GLP-1 medications Tirzepatide may produce slightly faster results than Semaglutide Appetite suppression often begins within the first 12 weeks Healthy weight loss averages 1 to 2.5 pounds per week Results depend on dosing, nutrition, activity, and consistency GLP-1 medications such as Semaglutide (Wegovy, Ozempic) and Tirzepatide (Zepbound, Mounjaro) are widely used in medical weight loss programs to help reduce appetite and support gradual fat loss
A significant number of mesopores (3 ~ 4 nm) were observed for pFeSAN due to the Hb pyrolysis in ZIF-8 (Fig